Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | DPP4 | P27487 | 2/20 | 0.53 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.53 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.53 |
| ▸ | TGFBR1 | P36897 | 3/20 | 0.50 |
| ▸ | MME | P08473 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | MMP9 | P14780 | 2/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.38 |
| ▸ | GRM6 | O15303 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5970410 | 1.00 | KMT2A (0.55) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL31696325 | 1.00 | KMT2A (0.55) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL31289501 | 0.95 | KMT2A (0.50) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL29630528 | 0.92 | ALOX15 (0.47) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL30462198 | 0.91 | DPP4 (0.52) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL30732345 | 0.90 | PTGS1 (0.45) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL31378335 | 0.89 | KMT2A (0.59) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL5970495 | 0.89 | KMT2A (0.59) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL19375 | 0.89 | KMT2A (0.59) | KMT2AALOX15BLMPMP22DPP4 | |
| SCHEMBL10532347 | 0.88 | DPP4 (0.54) | BLMDPP4DPP8DPP9TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116239666-A | Four goat milk chelated calcium peptides and preparation method thereof | 华南农业大学 | 2023-06-09 | — | — | CN | claimed |
| US-20220289846-A1 | ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 | ZYDUS LIFESCIENCES LIMITED (IN) | 2022-09-15 | — | — | US | claimed |
| EP-3997126-A1 | ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 | Cadila Healthcare Limited (IN) | 2022-05-18 | — | — | EP | claimed |
| CN-109311927-A | Sugar-dipeptides conjugates as flavor molecules | 雀巢产品技术援助有限公司 | 2019-02-05 | — | — | CN | claimed |
| EP-0457314-A1 | Nutrient compositions containing peptides | CLINTEC NUTRITION COMPANY (US) | 1991-11-21 | — | — | EP | claimed |
| CN-115850338-B | Bisaziridine-containing nucleoside compound and preparation method and application thereof | XI'AN JIAOTONG UNIVERSITY (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-20260085327-A1 | METABOLIC SELECTION VIA THE SERINE BIOSYNTHESIS PATHWAY | SIGMA ALDRICH CO LLC (US) | 2026-03-26 | — | — | US | disclosed |
| US-20260008830-A1 | THERAPEUTIC CYTOKINES AND METHODS | FUND CENTRE DE REGULACIO GENÒMICA (ES) | 2026-01-08 | — | — | US | disclosed |
| US-12516121-B2 | Antibodies to human programmed death receptor PD-1 | ZYDUS LIFESCIENCES LIMITED (IN) | 2026-01-06 | — | — | US | disclosed |
| CN-119033924-B | Development and application of porcine infectious pleuropneumonia subunit vaccine | 吉林大学 | 2025-04-11 | — | — | CN | disclosed |
| CN-119432787-A | 7 Beta hydroxysteroid dehydrogenase mutant and application thereof in preparation of UDCA | 湖北共同甾体药物研究院有限公司 | 2025-02-14 | — | — | CN | disclosed |
| US-20250032580-A1 | USE OF ADNF POLYPEPTIDES IN THERAPY | UNIV RAMOT (IL) | 2025-01-30 | — | — | US | disclosed |
| EP-3997126-A1 | ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 | Cadila Healthcare Limited (IN) | 2022-05-18 | — | — | EP | disclosed |
| US-20220088209-A1 | PEPTIDE LINKER AND COMBINATION FOR PRODRUGS ACTIVATED BY PROSTATE-SPECIFIC ANTIGEN | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2022-03-24 | — | — | US | disclosed |
| US-20190313679-A1 | SUGAR-DIPEPTIDE CONJUGATES AS FLAVOR MOLECULES | Société des Produits Nestlé S.A. (CH) | 2019-10-17 | — | — | US | disclosed |
| EP-3481840-A1 | SUGAR-DIPEPTIDE CONJUGATES AS FLAVOR MOLECULES | Nestec S.A. (CH) | 2019-05-15 | — | — | EP | disclosed |
| CN-109311927-A | Sugar-dipeptides conjugates as flavor molecules | 雀巢产品技术援助有限公司 | 2019-02-05 | — | — | CN | disclosed |
| WO-2018007495-A1 | SUGAR-DIPEPTIDE CONJUGATES AS FLAVOR MOLECULES | NESTEC S.A. (CH) | 2018-01-11 | — | — | WO | disclosed |
| US-20060217321-A1 | Compositions to improve tic disorders | TAIYOKAGAKU CO., LTD. (JP) | 2006-09-28 | — | — | US | disclosed |
| WO-1989007604-A1 | NOVEL GENES AND PLASMIDS AND TRANSFORMED BACTERIA CREATED THEREFROM | THE ROCKEFELLER UNIVERSITY (US) | 1989-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220088209-A1 | PEPTIDE LINKER AND COMBINATION FOR PRODRUGS ACTIVATED BY PROSTATE-SPECIFIC ANTIGEN | KLK3, DNPEP, FOLH1 | KMT2A 3018/4885ALOX15 4803/4885BLM 4645/4885 |
| US-20260085327-A1 | METABOLIC SELECTION VIA THE SERINE BIOSYNTHESIS PATHWAY | ASNS, PSPH, TYMS | KMT2A 2838/4885ALOX15 4641/4885BLM 3275/4885 |
| US-20260008830-A1 | THERAPEUTIC CYTOKINES AND METHODS | IL2, TNF, TNFSF11 | KMT2A 3782/4885ALOX15 4151/4885BLM 1008/4885 |
| US-20190313679-A1 | SUGAR-DIPEPTIDE CONJUGATES AS FLAVOR MOLECULES | TAS2R20, TAS2R40, TAS2R5 | KMT2A 1926/4885ALOX15 4632/4885BLM 4792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.